Literature DB >> 4200723

Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis.

M A Becker, P J Kostel, L J Meyer, J E Seegmiller.   

Abstract

Among affected members of a family (B. family) with excessive purine production and gout, activity of phosphoribosylpyrophosphate synthetase (EC 2.7.6.1) is 2.5- to 3.0-fold higher than among normal people. The molecular basis for this increased enzyme activity was studied. Antibody to purified human phosphoribosylpyrophosphate synthetase of erythrocytes was obtained from immunized rabbits. Studies with the IgG fraction of this antiserum show the presence of normal quantities of immunoreactive enzyme, but 2.5- to 3.0-fold higher activity per molecule in affected members of the B. family. In addition, by use of a stain for phosphoribosylpyrophosphate synthetase activity, a difference in electrophoretic mobility was demonstrated on cellulose acetate gel between the partially purified enzyme from normal people and an affected member of the B. family. These studies suggest that the enzyme aberration responsible for purine overproduction and gout in the B. family results from a structurally altered enzyme with increased activity per molecule.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4200723      PMCID: PMC427101          DOI: 10.1073/pnas.70.10.2749

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties.

Authors:  I H Fox; W N Kelley
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

Review 2.  Phosphoribosylpyrophosphate in man: biochemical and clinical significance.

Authors:  I H Fox; W N Kelley
Journal:  Ann Intern Med       Date:  1971-03       Impact factor: 25.391

3.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

4.  Substrate stabilization: genetically controlled reciprocal relationship of two human enzymes.

Authors:  M L Greene; J A Boyle; J E Seegmiller
Journal:  Science       Date:  1970-02-06       Impact factor: 47.728

5.  The multiple forms of mammalian hexokinase and their significance to the action of insulin.

Authors:  H M Katzen
Journal:  Adv Enzyme Regul       Date:  1967

6.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

7.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

8.  Amino acid substitution (histidine to tyrosine) in a glucose-6-phosphate dehydrogenase variant (G6PD Hektoen) associated with over-production.

Authors:  A Yoshida
Journal:  J Mol Biol       Date:  1970-09-28       Impact factor: 5.469

9.  Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.

Authors:  L J Strand; B F Felsher; A G Redeker; H S Marver
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

10.  Inosinic acid dehydrogenase activity in the Lesch-Nyhan syndrome.

Authors:  D M Pehlke; J A McDonald; E W Holmes; W N Kelley
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

View more
  19 in total

1.  Evidence for X-linkage of human phosphoribosylpyrophosphate synthetase.

Authors:  R C Yen; W B Adams; C Lazar; M A Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

Review 2.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

3.  Screening for metabolic disorders in children--aminoacidopathies.

Authors:  O S Reddi
Journal:  Indian J Pediatr       Date:  1977-02       Impact factor: 1.967

4.  Variation in alpha-L-fucosidase properties among 28 inbred mouse strains: six strains have high enzyme activity and heat-stabile enzyme with a variant pH-activity curve; twenty-two strains have low activity and heat-labile enzyme.

Authors:  W G Johnson; J L Hong
Journal:  Biochem Genet       Date:  1986-06       Impact factor: 1.890

5.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Characterization of beta-D-galactosidase isolated from I-cell disease liver.

Authors:  E W Holmes; A L Miller; R G Frost; J S O'Brien
Journal:  Am J Hum Genet       Date:  1975-11       Impact factor: 11.025

7.  Inherited disorders of purine metabolism--underlying molecular mechanisms.

Authors:  W Gutensohn
Journal:  Klin Wochenschr       Date:  1984-10-15

Review 8.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

9.  Purine oversecretion in cultured murine lymphoma cells deficient in adenylosuccinate synthetase: genetic model for inherited hyperuricemia and gout.

Authors:  B Ullman; M A Wormsted; M B Cohen; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Immunochemical studies on cultured fibroblasts from patients with inherited methylmalonic acidemia.

Authors:  J F Kolhouse; C Utley; W A Fenton; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.